Skip to content
thestock.space

Acutaas Chemicals (ACUTAAS) had a P/E of 70.9× on 6 Nov 2026, above the industry P/E of 22.1×. It earns ROCE of 28% and ROE of 26%, and sales and net profit grew 29% and 62% a year over 3 years. It has almost no debt, and its dividend yield is 0.1%. It is a small-cap company with a market cap of ₹31,001 Cr, ranked 7th of 204 Specialty Chemicals companies by market cap; the shares rose 106% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹3,760.00
Day high
₹3,820.00
Day low
₹3,704.90
Prev. close
₹3,770.80
Volume
2.7 L

Health check

4 good · 2 to check
  • ReturnsAhead

    +105.6% over a year, better than 7 of 7 peers.

  • Price tagPricier

    P/E 70.9 vs industry 22.1.

  • GrowthStrong

    Sales +29.4%, profit +62.3% a year over 3 years.

  • ProfitabilityStrong

    ROCE 27.7% vs peer median 21.0%.

  • Balance sheetSolid

    Practically debt-free, Piotroski 6 of 9.

  • Red flags1 to check

    P/E of 70.9 against an industry P/E of 22.1.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹31,001 Cr, #7 of 204 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Sep 2026: sales ₹1,593 Cr · profit ₹439 Cr
Market cap
₹31,001 Cr
Small cap
P/E
70.9
Industry 22.1
Price to book
16.69
Peers 11.23
Dividend yield
0.07%
ROE
26.1%
Peers 18.5%
ROCE
27.7%
Peers 21.0%
Debt to equity
0.01
Debt ₹15 Cr
EPS (TTM)
₹53.42
Face value ₹5
OPM (TTM)
39.4%
Net margin 27.6%
Sales growth
+42.7%
Latest quarter vs a year ago
Profit growth
+73.3%
Latest quarter vs a year ago
Price to sales
19.47
EV/EBITDA 49.4

Strengths and risks

Strengths

  • Return on equity of 26.1%.
  • Return on capital employed of 27.7%.
  • Practically debt-free.
  • Quarterly profit up 73.3% on a year ago.
  • Quarterly sales up 42.7% on a year ago.

Risks to check

  • P/E of 70.9 against an industry P/E of 22.1.

Derived automatically from reported figures. Not a recommendation.

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens,…

Headquarters
Surat
Employees
1,007
Sector
Basic Materials
ISIN
INE00FF01025
Website
acutaas.com

Price range

52 weeks

₹1,570.00₹4,045.30

Today

₹3,704.90₹3,820.00
Avg volume (3M)
5 L
1-year return
plus 105.6%
From 52-week high
minus 6.4%

Analyst consensus

9 analysts
BuyMean target ₹3,649.67 minus 3.6%

The mean target is below today’s price.

Target range, with today’s price

Low ₹1,783.00High ₹4,693.00

Consensus from Yahoo Finance. Not a recommendation.

Peers · Specialty Chemicals

Compare with peersScreen the whole industry
Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.511.2324.4%23.0%18.9%1.1%1.7%1.13%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.421.9429.5%35.1%27.8%12.4%30.4%0.06%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.014.3328.5%25.7%23.5%7.4%24.4%0.73%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.413.3316.3%11.8%31.5%––0.06%plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.47.8820.6%18.4%15.3%4.2%9.4%0.84%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.96.119.6%8.3%24.1%−4.5%−24.3%0.06%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.916.6927.7%26.1%39.4%29.4%62.3%0.07%plus 105.6%
HSCLHimadri Speciality Chemical568.15minus 0.07%28,66733.55.5821.0%18.5%21.8%3.7%51.5%0.14%plus 22.9%
Median of 7 peers–0.48%58,49660.011.2321.0%18.5%23.5%4.0%16.9%0.14%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26Sep 26
207–393422330437
156–243238217261
50.9–151184113176
24.6%–38.3%43.6%34.3%40.3%
15.9–4.7101.85.1
0.6–0.90.71.11
8.1–9.89.69.812.7
–––0––
58.1–145184104167
24.2%–26.6%26.9%27.8%26.4%
–72.210813274.3125
5.41–13.10–9.0415.24

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+29.4%
Profit CAGR 3Y
+62.3%
EPS CAGR 3Y
+96.5%
ROE
26.1%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
6137131,0001,329
–+16.3%+40.2%+32.9%
490609768848
123104232481
20.1%14.6%23.2%36.2%
4.331.916.340.5
2.45.95.62.8
12.316.126.636
−0.7−31.900
11281.9216483
25.7%40.5%25.8%26.2%
83.342.8159356
–minus 48.6%+271.1%+124.5%
11.435.8319.8143.37

EPS is shown as reported. The EPS CAGR above adjusts earlier years for the 2:1 on Apr 2025 split/bonus; dilution from new shares is not adjusted.

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
36.436.940.940.9
5586371,2691,613
3.621712.935.6
169205227295
7671,0961,5491,984
260530687983
38.5170182349
3.30.90.20.2
58.753.3249225
406341431427
7671,0961,5491,984

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
65.5125118292
−33−365−224−266
−12.32392614.1
20.2−0.915630.3
−96.4−315−195−328
−30.9−190−76.3−35.8
−10.9−10.9−12.3−12.3

Shareholding pattern

Source: NSE filings
32.7%
promoters
  • Promoters32.66%
  • Public67.34%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202632.66%67.34%0.00
30 Jun 202632.66%67.34%0.00
31 Mar 202632.66%67.34%0.00
31 Dec 202532.66%67.34%0.00
30 Sep 202532.66%67.34%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you